About
TxCell develops and manufactures cell-based immunotherapies, primarily focusing on vaccines and treatments for cancer and infectious diseases using dendritic cell technology.
Explore TxCell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.